Nordic Walking exercise for Osteoporosis

Phase-Based Progress Estimates
Osteoporosis+2 MoreNordic Walking exercise - Behavioral
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial will study whether Nordic walking helps improve mobility, physical function, posture, and quality of life for people with osteoporosis, a history of osteoporotic fracture, or hyperkyphosis.

Eligible Conditions
  • Osteoporosis
  • Kyphosis
  • Vertebral Fractures

Treatment Effectiveness

Study Objectives

2 Primary · 9 Secondary · Reporting Duration: 20-30 minutes

10-20 minutes
Proximal femur bone mineral density (g/cm^2)
Total body lean tissue mass (g)
16-20 minutes
2-4 minutes
Muscle strength
2-5 minutes
Fear of falling
Physical activity exercise confidence
20-30 minutes
Bone and muscle properties and estimated bone strength of the lower leg and forearm
3-5 minutes
Functional balance
Kyphosis angle
5-10 minutes
Quality of life score
7 days
Physical activity

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
Nordic walking
1 of 2

Active Control

Experimental Treatment

160 Total Participants · 2 Treatment Groups

Primary Treatment: Nordic Walking exercise · No Placebo Group · N/A

Nordic walking
Experimental Group · 1 Intervention: Nordic Walking exercise · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 20-30 minutes

Who is running the clinical trial?

University of SaskatchewanLead Sponsor
237 Previous Clinical Trials
90,155 Total Patients Enrolled
8 Trials studying Osteoporosis
1,305 Patients Enrolled for Osteoporosis
Royal University Hospital FoundationOTHER
22 Previous Clinical Trials
6,711 Total Patients Enrolled
Saskatchewan Health Research FoundationOTHER
29 Previous Clinical Trials
4,455 Total Patients Enrolled
1 Trials studying Osteoporosis
73 Patients Enrolled for Osteoporosis
Saskatchewan Centre for Patient-Oriented ResearchOTHER
11 Previous Clinical Trials
1,809 Total Patients Enrolled
Saija Kontulainen, PhDPrincipal InvestigatorUniversity of Saskatchewan

Eligibility Criteria

Age Any Age · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: